Canigen DH (A2) PPIL Formulation: Each 1 mL (dose) contains: Canine Distemper Virus (Laderle Strain) ............ 103-4.9 CCID50 Canine Adenovirus Type 2 (Manhattan Strain) ..... 104-6 CCID 50 Canine Parvovirus (CPV 780916 Strain) ............................. 105-6,8 CCID50 Canine Parainfluenza Virus (Manhattan Strain) ................. 105-6.9 CCID 50 Leptospira interrogans ser. Canicola .................................... 4350-7330 U (antigenic mass) ser. Icterohaemorrhagiae .............. 4250-6910 U (antigenic mass) CCID- Cell Culture Infective Dose U-ELISA Freeze-Dried Pellet for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

canigen dh (a2) ppil formulation: each 1 ml (dose) contains: canine distemper virus (laderle strain) ............ 103-4.9 ccid50 canine adenovirus type 2 (manhattan strain) ..... 104-6 ccid 50 canine parvovirus (cpv 780916 strain) ............................. 105-6,8 ccid50 canine parainfluenza virus (manhattan strain) ................. 105-6.9 ccid 50 leptospira interrogans ser. canicola .................................... 4350-7330 u (antigenic mass) ser. icterohaemorrhagiae .............. 4250-6910 u (antigenic mass) ccid- cell culture infective dose u-elisa freeze-dried pellet for injection (sc)

virbac philippines inc. - live attenuated canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , inactivated leptospira interrogans var. canicola , l. interrogans var. icterohaemorrhagiae vaccine (vet.) - freeze-dried pellet for injection (sc) - formulation: each 1 ml (dose) contains: canine distemper virus (laderle strain) ............ 103-4.9 ccid50 canine adenovirus type 2 (manhattan strain) ..... 104-6 ccid 50 canine parvovirus (cpv 780916 strain) ............................. 105-6,8 ccid50 canine parainfluenza virus (manhattan strain) ................. 105-6.9 ccid 50 leptospira interrogans ser. canicola .................................... 4350-7330 u (antigenic mass) ser. icterohaemorrhagiae .............. 4250-6910 u (antigenic mass) ccid- cell culture infective dose u-elisa

Biocan DHPPiLR Formulation: Each mL (dose) contains: Canine Distemper Virus (CDV)...................>10^3 TCID50 Canine Adenovirus Type 2 (CAV-2)....................>10^3 TCID50 Canine Parvovirus (CPV)...............>10^4.5 TCID50 Canine Parainfluenza Virus (CPIV).............>10^3 TCID50 Leptospira interrogans var. Icterohaemorrhagiae............................>10^7 titer Leptospira interrogans var. Grippotyphosa......... .. >10^7 titer Leptospira interrogans var. Canicola............>10^7 titer Rabies Virus........... > 2 IU TCID - Tissue Culture Infectious Dose IU - International Unit Freeze-dried Powder for Injection (IM/SC) Philippines - English - FDA (Food And Drug Administration)

biocan dhppilr formulation: each ml (dose) contains: canine distemper virus (cdv)...................>10^3 tcid50 canine adenovirus type 2 (cav-2)....................>10^3 tcid50 canine parvovirus (cpv)...............>10^4.5 tcid50 canine parainfluenza virus (cpiv).............>10^3 tcid50 leptospira interrogans var. icterohaemorrhagiae............................>10^7 titer leptospira interrogans var. grippotyphosa......... .. >10^7 titer leptospira interrogans var. canicola............>10^7 titer rabies virus........... > 2 iu tcid - tissue culture infectious dose iu - international unit freeze-dried powder for injection (im/sc)

broadchem philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , inactivated leptospira interrogans var. icterohaemorrhagiae , leptospira interrogans var. grippotyphosa , leptospira interrogans var. canicola , rabies virus (rv) vaccine (vet.) - freeze-dried powder for injection (im/sc) - formulation: each ml (dose) contains: canine distemper virus (cdv)...................>10^3 tcid50 canine adenovirus type 2 (cav-2)....................>10^3 tcid50 canine parvovirus (cpv)...............>10^4.5 tcid50 canine parainfluenza virus (cpiv).............>10^3 tcid50 leptospira interrogans var. icterohaemorrhagiae............................>10^7 titer leptospira interrogans var. grippotyphosa......... .. >10^7 titer leptospira interrogans var. canicola............>10^7 titer rabies virus........... > 2 iu tcid - tissue culture infectious dose iu - international unit

Canvac DHPPiL + R Formulation: Each mL (dose) contains: Live Attenuated Canine Distemper Virus (CDV)...... >10^2.7-4.5 EID50 Canine Adenovirus Type 1 (CAV-1). .................. >10^3.5-7.5 TCID 50 Canine Adenovirus Type 2 (CAV-2)................... >10^3.5-7.5 TCID50 Canine Parvovirus (CPV)............. >10^2.1-3.6 HAU Canine Parainfluenza Virus (CPIV)..................... >10^3-6 CCID 50 Inactivated Leptospira interrogans var. Icterohaemorrhagiae....... >32 VNAb50 Leptospira interrogans var. Grippotyphosa.......>32 VNAb50 Leptospira interrogans var. Sejroe............... >32 VNAb 50 Rabies Virus (RV)................ >2 IU EID - Egg Infectious Dose TCID-Tissue Culture Infectious Dose CCID-Cell Culture Infectious Dose HAU - Haemagglutination Unit IU - International Unit Freeze-dried Powder for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

canvac dhppil + r formulation: each ml (dose) contains: live attenuated canine distemper virus (cdv)...... >10^2.7-4.5 eid50 canine adenovirus type 1 (cav-1). .................. >10^3.5-7.5 tcid 50 canine adenovirus type 2 (cav-2)................... >10^3.5-7.5 tcid50 canine parvovirus (cpv)............. >10^2.1-3.6 hau canine parainfluenza virus (cpiv)..................... >10^3-6 ccid 50 inactivated leptospira interrogans var. icterohaemorrhagiae....... >32 vnab50 leptospira interrogans var. grippotyphosa.......>32 vnab50 leptospira interrogans var. sejroe............... >32 vnab 50 rabies virus (rv)................ >2 iu eid - egg infectious dose tcid-tissue culture infectious dose ccid-cell culture infectious dose hau - haemagglutination unit iu - international unit freeze-dried powder for injection (sc)

broadchem philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine adenovirus type 1 (cav-1) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , inactivated leptospira interrogans var. icterohaemorrhagiae , leptospira interrogans var. grippotyphosa , leptospira interrogans var. sejroe , rabies virus (rv) vaccine (vet.) - freeze-dried powder for injection (sc) - formulation: each ml (dose) contains: live attenuated canine distemper virus (cdv)...... >10^2.7-4.5 eid50 canine adenovirus type 1 (cav-1). .................. >10^3.5-7.5 tcid 50 canine adenovirus type 2 (cav-2)................... >10^3.5-7.5 tcid50 canine parvovirus (cpv)............. >10^2.1-3.6 hau canine parainfluenza virus (cpiv)..................... >10^3-6 ccid 50 inactivated leptospira interrogans var. icterohaemorrhagiae....... >32 vnab50 leptospira interrogans var. grippotyphosa.......>32 vnab50 leptospira interrogans var. sejroe............... >32 vnab 50 rabies virus (rv)................ >2 iu eid - egg infectious dose tcid-tissue culture infectious dose ccid-cell culture infectious dose hau - haemagglutination unit iu - international unit

Canvac 8 DHPPiL Formulation: Each mL (dose) contains: Canine Distemper Virus (CDV)..... ...........>10^2.7-4.5 EID50 Canine Adenovirus Type 1 (CAV-1)......................>10^3.5-7.5 TCID50 Canine Adenovirus Type 2 (CAV-2)..................... >10^3.5-7.5 TCID50 Canine Parvovirus (CPV).................................. >10^2.1-3,6 HAU Canine Parainfluenza Virus (CPIV)...................... >10^3-6 CCID50 Leptospira interrogans var. Icterohaemorrhagiae........ >1:32 titer Leptospira interrogans var. Grippotyphosa............... >1:32 titer Leptospira interrogans var. Sejroe...................>1:32 titer EID - Egg Infectious Dose TCID-Tissue Culture Infectious Dose CCID-Cell Culture Infectious Dose HAU - Hemagglutination Unit IU - International Unit Freeze-dried Powder for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

canvac 8 dhppil formulation: each ml (dose) contains: canine distemper virus (cdv)..... ...........>10^2.7-4.5 eid50 canine adenovirus type 1 (cav-1)......................>10^3.5-7.5 tcid50 canine adenovirus type 2 (cav-2)..................... >10^3.5-7.5 tcid50 canine parvovirus (cpv).................................. >10^2.1-3,6 hau canine parainfluenza virus (cpiv)...................... >10^3-6 ccid50 leptospira interrogans var. icterohaemorrhagiae........ >1:32 titer leptospira interrogans var. grippotyphosa............... >1:32 titer leptospira interrogans var. sejroe...................>1:32 titer eid - egg infectious dose tcid-tissue culture infectious dose ccid-cell culture infectious dose hau - hemagglutination unit iu - international unit freeze-dried powder for injection (sc)

broadchem philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine adenovirus type 1 (cav-1) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , inactivated leptospira interrogans var. icterohaemorrhagiae , leptospira interrogans var. grippotyphosa , leptospira interrogans var. sejroe vaccine (vet.) - freeze-dried powder for injection (sc) - formulation: each ml (dose) contains: canine distemper virus (cdv)..... ...........>10^2.7-4.5 eid50 canine adenovirus type 1 (cav-1)......................>10^3.5-7.5 tcid50 canine adenovirus type 2 (cav-2)..................... >10^3.5-7.5 tcid50 canine parvovirus (cpv).................................. >10^2.1-3,6 hau canine parainfluenza virus (cpiv)...................... >10^3-6 ccid50 leptospira interrogans var. icterohaemorrhagiae........ >1:32 titer leptospira interrogans var. grippotyphosa............... >1:32 titer leptospira interrogans var. sejroe...................>1:32 titer eid - egg infectious dose tcid-tissue culture infectious dose ccid-cell culture infectious dose hau - hemagglutination unit iu - international unit

Biocan Novel DHPPI/L4 Each mL (1 dose) contains: Lyophilisate (Live Attenuated): Canine Distemper Virus, strain CDV Bio 11/A 103.1-5. TCID50 Canine Adenovirus Type 2, strain CAV-2 Bio 13 103.6-5.3. TCID50 Canine Parvovirus Type 2b, strain CPV-2b Bio 12/B 104.3-6.6 TCID50 Canine Parainfluenza Type 2 Virus, strain CPIV-2 Bio 15- 103.1:5.1 TCID50 TCID – Tissue Culture Infectious Dose Suspension (Inactivated): Leptospira interrogans serogroup Icterohaemorrhagiae Serovar Icterohaemorrhagiae, strain MSLB 1089 GMT 1:51 ALR Leptospira interrogans serogroup Canicola, Serovar Canicola, strain MSLB 1090 GMT 1:51 ALR Leptospira kirschneri serogroup Grippotyphosa, Serovar Grippotyphosa, strain MSLB 1091 21:40 ALR Leptospira interrogans serogroup Australis, Serovar Bratislava, strain MSLB 1088 GMT 1:51 ALR ALR - Antibody micro agglutination-lytic reaction GMT-Geometric Mean Titre Solution For Injection (IM) Philippines - English - FDA (Food And Drug Administration)

biocan novel dhppi/l4 each ml (1 dose) contains: lyophilisate (live attenuated): canine distemper virus, strain cdv bio 11/a 103.1-5. tcid50 canine adenovirus type 2, strain cav-2 bio 13 103.6-5.3. tcid50 canine parvovirus type 2b, strain cpv-2b bio 12/b 104.3-6.6 tcid50 canine parainfluenza type 2 virus, strain cpiv-2 bio 15- 103.1:5.1 tcid50 tcid – tissue culture infectious dose suspension (inactivated): leptospira interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089 gmt 1:51 alr leptospira interrogans serogroup canicola, serovar canicola, strain mslb 1090 gmt 1:51 alr leptospira kirschneri serogroup grippotyphosa, serovar grippotyphosa, strain mslb 1091 21:40 alr leptospira interrogans serogroup australis, serovar bratislava, strain mslb 1088 gmt 1:51 alr alr - antibody micro agglutination-lytic reaction gmt-geometric mean titre solution for injection (im)

broadchem philippines biopharma corporation; distributor: broadchem philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine parainfluenza virus (cpiv) , canine adenovirus (cav) , canine parvovirus (cpv) , inactivated leptospira interrogans icterohaemorrhagiae , leptospira interrogans canicola , leptospira vaccine (vet.) - solution for injection (im) - each ml (1 dose) contains: lyophilisate (live attenuated): canine distemper virus, strain cdv bio 11/a 103.1-5. tcid50 canine adenovirus type 2, strain cav-2 bio 13 103.6-5.3. tcid50 canine parvovirus type 2b, strain cpv-2b bio 12/b 104.3-6.6 tcid50 canine parainfluenza type 2 virus, strain cpiv-2 bio 15- 103.1:5.1 tcid50 tcid – tissue culture infectious dose suspension (inactivated): leptospira interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089 gmt 1:51 alr leptospira interrogans serogroup canicola, serovar canicola, strain mslb 1090 gmt 1:51 alr leptospira kirschneri serogroup grippotyphosa, serovar grippotyphosa, strain mslb 1091 21:40 alr leptospira interrogans serogroup australis, serovar bratislava, strain mslb 1088 gmt 1:51 alr alr - antibody micro agglutination-lytic reaction gmt-geometric mean titre

Versican Plus DHPPi/L4R European Union - English - EMA (European Medicines Agency)

versican plus dhppi/l4r

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

Biocan Novel DHPPi L4R Formulation: Each dose (1 mL) contains: Canine Distemper Virus (CDV Bio 11/A strain)- 10^3.1 to 10^5.1 TCID50 Canine Parainfluenza Type 2 Virus (CPIV-2-Bio 15 strain)-- 10^3.1 to 10^5.1 TCID50 Canine Adenovirus Type 2 (CAV-2-Bio 13 strain)-10^3.6 to 10^5.3 TCID50 Canine Parvovirus Type 2b (CPV-2b Bio 12/B strain)-10^4.3 to 10^6.6 TCID50 Leptospira interrogans ser. Icterohaemorrhagiae (MSLB 1089 strain)- >1:51 ALR (GMT) ser. Canicola (MSLB 1090 strain)-- >1:51 ALR (GMT) ser. Bratislava (MSLB 1088 strain)- >1:51 ALR (GMT) Leptospira kirschneri ser. Grippotyphosa (MSLB 1091 strain)- >1:40 ALR (GMT) Rabies Virus (SAD Vnukovo-32 Bio 16 strain)-> 2.0 IU TCID-Tissue Culture Infect Dose 50% GMT-Geometric Moon Titre ALR-Agglutination Lyuis Reacties Freeze-dried powder for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

biocan novel dhppi l4r formulation: each dose (1 ml) contains: canine distemper virus (cdv bio 11/a strain)- 10^3.1 to 10^5.1 tcid50 canine parainfluenza type 2 virus (cpiv-2-bio 15 strain)-- 10^3.1 to 10^5.1 tcid50 canine adenovirus type 2 (cav-2-bio 13 strain)-10^3.6 to 10^5.3 tcid50 canine parvovirus type 2b (cpv-2b bio 12/b strain)-10^4.3 to 10^6.6 tcid50 leptospira interrogans ser. icterohaemorrhagiae (mslb 1089 strain)- >1:51 alr (gmt) ser. canicola (mslb 1090 strain)-- >1:51 alr (gmt) ser. bratislava (mslb 1088 strain)- >1:51 alr (gmt) leptospira kirschneri ser. grippotyphosa (mslb 1091 strain)- >1:40 alr (gmt) rabies virus (sad vnukovo-32 bio 16 strain)-> 2.0 iu tcid-tissue culture infect dose 50% gmt-geometric moon titre alr-agglutination lyuis reacties freeze-dried powder for injection (sc)

broadchem philippines biopharma corporation; distributor: broadchem philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine parainfluenza virus , canine adenovirus (cav) , canine parvovirus , inactivated leptospira interrogans ser. icterohaemorrhagiae , l. interrogans ser. canicola , l. kirschneri ser. grippotyphosa , l. interrogans ser. bratislava , rabies virus vaccine (vet.) - freeze-dried powder for injection (sc) - formulation: each dose (1 ml) contains: canine distemper virus (cdv bio 11/a strain)- 10^3.1 to 10^5.1 tcid50 canine parainfluenza type 2 virus (cpiv-2-bio 15 strain)-- 10^3.1 to 10^5.1 tcid50 canine adenovirus type 2 (cav-2-bio 13 strain)-10^3.6 to 10^5.3 tcid50 canine parvovirus type 2b (cpv-2b bio 12/b strain)-10^4.3 to 10^6.6 tcid50 leptospira interrogans ser. icterohaemorrhagiae (mslb 1089 strain)- >1:51 alr (gmt) ser. canicola (mslb 1090 strain)-- >1:51 alr (gmt) ser. bratislava (mslb 1088 strain)- >1:51 alr (gmt) leptospira kirschneri ser. grippotyphosa (mslb 1091 strain)- >1:40 alr (gmt) rabies virus (sad vnukovo-32 bio 16 strain)-> 2.0 iu tcid-tissue culture infect dose 50% gmt-geometric moon titre alr-agglutination lyuis reacties

VANGUARD 7. Ireland - English - HPRA (Health Products Regulatory Authority)

vanguard 7.

zoetis belgium s.a. - canine distemper virus strain n-cdv (live, attenuated); canine adenovirus type 2 virus, strain manhattan (live, attenuated); canine parainfluenza type 5 virus, strain nl-cpi-5 (live, attenuated); canine parvovirus strain nl-35-d (live, attenuated); leptospira canicola inactivated ; leptospira icterohaemorrhagiae inactivated - lyophilisate and solvent for solution for injection - . - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira - dogs - immunological - mixed vaccine (l & a)

VANGUARD 7 Ireland - English - HPRA (Health Products Regulatory Authority)

vanguard 7

zoetis ireland limited - canine distemper virus strain n-cdv (live, attenuated), canine adenovirus type 2 virus, strain manhattan (live, attenuated), canine parainfluenza type 5 virus, strain nl-cpi-5 (live, attenuated), canine parvovirus, strain nl-35-d, live attenuated, leptospira icterohaemorrhagiae inactivated, leptospira canicola inactivated - lyophilisate and solvent for solution for injection - %v/v - live canine distemper virus vaccine + live canine adenovirus vaccine + live canine parainfluenza vi - canine - immunological - mixed vaccine (live and inactivated)

Versican Plus DHPPi/L4 European Union - English - EMA (European Medicines Agency)

versican plus dhppi/l4

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 6 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae and to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa.